FI971403L - Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi - Google Patents

Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi Download PDF

Info

Publication number
FI971403L
FI971403L FI971403A FI971403A FI971403L FI 971403 L FI971403 L FI 971403L FI 971403 A FI971403 A FI 971403A FI 971403 A FI971403 A FI 971403A FI 971403 L FI971403 L FI 971403L
Authority
FI
Finland
Prior art keywords
vaccines containing
enteric bacteria
producing enhanced
enhanced antigenic
antigenic
Prior art date
Application number
FI971403A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971403A7 (fi
FI971403A0 (fi
Inventor
John L Pace
Richard I Walker
Steven M Frey
Original Assignee
Microcarb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Microcarb Inc filed Critical Microcarb Inc
Publication of FI971403A0 publication Critical patent/FI971403A0/fi
Publication of FI971403A7 publication Critical patent/FI971403A7/fi
Publication of FI971403L publication Critical patent/FI971403L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI971403A 1994-10-05 1995-10-04 Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi FI971403L (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
PCT/US1995/013196 WO1996011258A1 (en) 1994-10-05 1995-10-04 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same

Publications (3)

Publication Number Publication Date
FI971403A0 FI971403A0 (fi) 1997-04-04
FI971403A7 FI971403A7 (fi) 1997-06-04
FI971403L true FI971403L (fi) 1997-06-04

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971403A FI971403L (fi) 1994-10-05 1995-10-04 Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi

Country Status (16)

Country Link
EP (1) EP0804542A4 (de)
JP (1) JP3394047B2 (de)
CN (1) CN1168693A (de)
AU (1) AU704283B2 (de)
BR (1) BR9509276A (de)
CA (1) CA2202027A1 (de)
CZ (1) CZ104397A3 (de)
FI (1) FI971403L (de)
HU (1) HUT77876A (de)
IL (1) IL115521A0 (de)
MX (1) MX9702431A (de)
NO (1) NO971519L (de)
NZ (1) NZ295907A (de)
PL (1) PL182700B1 (de)
SG (2) SG73510A1 (de)
WO (1) WO1996011258A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE310803T1 (de) * 1994-10-05 2005-12-15 Antex Biolog Inc Verfahren zur produktion von verstärkt antigen wirkenden heliobacter sp. und vakzine die diesen enthalten
US20080175856A1 (en) * 2003-05-30 2008-07-24 Intercell Ag Enterococcus Antigens
EP1996228A4 (de) * 2006-03-17 2009-08-26 Cerebus Biolog Inc Impfstoffe gegen campylobacter und anwendungsverfahren
WO2008146830A1 (ja) * 2007-05-28 2008-12-04 The Kitasato Institute パラ百日咳菌全菌体ワクチン組成物
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
WO2020141103A1 (en) 2018-12-31 2020-07-09 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096650A1 (en) * 1991-09-18 1993-03-21 Keith E. Langley Hepatitis b vaccine formulation incorporating a bile acid salt

Also Published As

Publication number Publication date
MX9702431A (es) 1998-05-31
WO1996011258A1 (en) 1996-04-18
AU3956195A (en) 1996-05-02
CZ104397A3 (cs) 1998-06-17
FI971403A7 (fi) 1997-06-04
HUT77876A (hu) 1998-09-28
SG73510A1 (en) 2000-06-20
CN1168693A (zh) 1997-12-24
PL319580A1 (en) 1997-08-18
AU704283B2 (en) 1999-04-15
EP0804542A1 (de) 1997-11-05
SG73509A1 (en) 2000-06-20
CA2202027A1 (en) 1996-04-18
FI971403A0 (fi) 1997-04-04
JP3394047B2 (ja) 2003-04-07
EP0804542A4 (de) 1998-10-28
IL115521A0 (en) 1996-06-18
PL182700B1 (pl) 2002-02-28
BR9509276A (pt) 1997-11-18
NZ295907A (en) 1999-04-29
NO971519D0 (no) 1997-04-03
JPH10507347A (ja) 1998-07-21
NO971519L (no) 1997-05-27

Similar Documents

Publication Publication Date Title
FI955727L (fi) Menetelmä ja laite liposomien valmistamiseksi
FI971530A7 (fi) Lipaasi, sitä tuottava mikro-organismi, menetelmä lipaasin valmistamis eksi ja sen käyttö
FI953731L (fi) Menetelmä PRRS-viruksen viljelemiseksi ja sen käyttö rokotteissa
FI960948A7 (fi) Pakkaus ja menetelmä mainitun pakkauksen tuottamiseksi
FI955362A0 (fi) Symmetrointilaite ja menetelmä sen suunnittelemiseksi
FI951305L (fi) Lääketieteellinen materiaali ja menetelmä sen valmistamiseksi
FI951184A7 (fi) Taikinaa sisältävä yhdistelmä sekä menetelmä sen valmistamiseksi
FI922854L (fi) Menetelmä ja laite kuitujen valmistusta varten
FI973378A0 (fi) Laite ja menetelmä
HU9602310D0 (en) Urease-based vaccine and treatment for helicobacter infection
EP0555366A4 (en) Bacterial attenuation method and vaccine
NO950205D0 (no) Framgangsmåte og anordning for framstilling av emballasje
FI964083A7 (fi) Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä
FI962486A7 (fi) Pakkaus ja menetelmä sekä laite sen valmistamiseksi
FI961937L (fi) Juoma ja menetelmä sen valmistamiseksi
FI930266L (fi) Vateriitti ja menetelmä sen valmistamiseksi
FI953524A0 (fi) Menetelmä ja laite avosuisten lasitavaroiden valmistamiseksi
FI971403A7 (fi) Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi
FI941414A7 (fi) Menetelmä ja laitteisto bioproteiinien valmistamiseksi
DE69515600D1 (de) Synchronisationsvorrichtung und -verfahren
FI971402L (fi) Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi
FI954408L (fi) Laite ja menetelmä paistamista varten
FI956239A7 (fi) Menetelmä selvästi merkittyjen, silikonista muodostuvien esineiden valmistamiseksi ja niiden käyttö
FI911989A7 (fi) Lomake ja menetelmä
DE69312971D1 (de) Methode und Mittel zur Herstellung von Gehrungsfugen

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ANTEX BIOGICS, INC.

MA Patent expired